• Skip to main content

Allergy Partners

  • Find a New Location
  • Patient Portal
  • Bill Pay
  • Become an Allergy Partner
  • Site Search
  • Providers
  • Services
        • Treatment
          • Allergy Shots (Subcutaneous Immunotherapy, SCIT)
          • Biologics
          • Medications
          • Food Allergy Risk Reduction (FARR®)
          • Food Oral Immunotherapy (Food OIT)
          • Food Sublingual Immunotherapy (Food SLIT)
          • Environmental Sublingual Immunotherapy (Environmental SLIT)
        • Testing
          • Blood Testing
          • Food Allergy Testing
          • Patch Testing
          • Pulmonary Function Testing
          • Restech Testing
          • Skin Testing
  • Conditions
        • Food/ Gastrointestinal
          • Eosinophilic Esophagitis
          • Food Allergies
          • Laryngopharyngeal Reflux Disease
        • Lung
          • Asthma
          • Chronic Cough
        • Nasal, Sinus, Eye
          • Environmental Allergies
          • Eye Allergies (Allergic Conjunctivitis)
          • Nasal Polyps
          • Sinusitis
          • Vasomotor Rhinitis/ Chronic Rhinitis
        • Other Conditions
          • Anaphylaxis
          • Immune Deficiency
          • Medication Allergy
          • Recurrent Infections
          • Stinging Insect Allergy
          • Pediatric Allergies
        • Skin Allergies and Conditions
          • Angioedema
          • Contact Dermatitis
          • Eczema (Atopic Dermatitis)
          • Hives/Urticaria
          • Latex Allergy
          • Metal Allergy
  • About Us
        • About Us
        • Blog
        • Careers
        • Clinical Research
        • Pharmacy
        • What Is an Allergist?
        • In The News
  • Patient Resources
        • Pathway to Relief
        • Patient Portal
        • Bill Pay
        • Video Center
        • New Patient Forms & Resources
        • Request Medical Records
        • Patient Rights
        • Notice of Privacy Practices
  • Find a Location

Search Results for:

Beyond a Sinus Infection

March 30, 2023 by

Beyond a Sinus Infection

by Allergy Partners
March 30, 2023

disabled girl with her dog

Article by Dr. Michael Martucci | Allergy Partners of Northern Colorado

When Is a Sinus Infection More Than “Just” a Sinus Infection?

Of course, go figure, it is Friday at 6:00 PM and all the doctor’s offices have closed. I had been putting off going to the doctor in hopes that my symptoms would improve. It all started a few weeks ago with sneezing, nasal congestion and runny nose. That pesky ragweed, I thought to myself. As the week went on, I started to experience cough and green mucous discharge coming from my nose. This had started to become a recurring thing over the past year, 5 times to be exact. I was always told it is just a cold and to drink plenty of fluid and rest. I was starting to feel like I would never get better as antibiotics seemed to help, but never completely resolved my symptoms. Should I call the on-call doctor, go to urgent care, Google it, or just keep feeling sick. I needed answers.

What Are Sinuses?

Sinuses are air-filled spaces located behind the bones of the upper face, including the cheeks, nose and forehead. The lining of the sinuses is made up of cells with tiny hairs on their surfaces called cilia. Other cells in the lining produce mucus. The mucus traps germs and pollutants and the cilia push the mucus out through narrow sinus openings into the nose.

Inflammation

When the sinuses become inflamed or infected, the mucus thickens and clogs the openings to one or more sinuses. Fluid builds up inside the sinuses causing increased pressure, pain and headaches. Also, bacteria may become trapped and infect the lining of the sinuses.

Chronic vs. Acute

Sinusitis may be chronic-long-lasting and frequently returning-or may be acute. Acute sinusitis lasts less than 2-3 weeks and occurs less than three times a year. Acute sinusitis is extremely common and is typically caused by a viral infection. It may also be triggered by allergies, air pollution, cigarette smoke, dental infections and/or nasal polyps. It typically does not require treatment with antibiotics and resolves on its own.

Similarities

Chronic sinusitis and acute sinusitis have similar signs and symptoms. Distinguishing factors for more severe disease include length of infection, frequency of infections and difficult to treat infections. Red flags are raised with family history, persistent, complicated or unusual infections. These warning signs prompt further evaluation by your Allergy Partners Physician.

Recommendations

The Immune Deficiency Foundation recommends screening for a possible immune deficiency if you have had more than 4-5 sinus infections in a year. It is important to distinguish between allergies, infection and antibody deficiencies. This can be done with skin testing and/or blood tests. There are several different treatment options depending on the cause of your sinus infection.

If you are unsure what is triggering your sinus symptoms and unclear where to turn, contact your Allergy Partners physician who will listen, diagnose, treat and ultimately have you feeling your best.

  • Providers
  • Services
  • Conditions
  • About Us
  • Careers
  • Find A Location
  • Patient Resources
  • Become an Allergy Partner
  • Blog
  • Allergy Partners Shop
Allergy Partners Home
  •  

© 2024 All Rights Reserved.

    • Notice of Privacy Practices
    • Patient Rights
    • Site Privacy Policy
    • Site Terms of Use
    • Site Accessibility
    • Site Search
    • Employee Healthcare Info
    • Site Map

Filed Under: Environmental Allergy

Dust Mite Allergy

March 29, 2023 by

Dust Mite Allergy

by Allergy Partners
March 29, 2023

woman sleeping on the bed

Year round symptoms due to dust mites are experienced by millions of people. Dust mite allergens can be found throughout your house but most often live in warm, humid environments including beds, carpet, and upholstered furniture. These allergens can trigger a variety of symptoms including nasal, ocular, pulmonary, and skin inflammation. Because of this heterogeneity, diagnosis can be difficult. If dust mite or other indoor allergies are suspected, patients should consult a board certified allergist for further evaluation. This evaluation typically includes taking a detailed history including environmental exposure, physical exam and testing. Testing for dust mite allergies typically includes either a skin prick test or blood test (ImmunoCAP IgE) for the two main species of dust mites, Dermatophagoides pteronyssinus and Dermatophagoides farina.

Treatment for dust mite allergies includes reducing exposure to the allergen, pharmacotherapy, and immunotherapy. Allergy Partners has teamed with
Allergy Guardian to provide dust mite fabric covers for pillows, mattresses, and box springs. Removing carpet and regular vacuuming can help limit exposure to dust mites. Pharmacotherapy is guided by patient symptoms. This typically includes the use of oral or intranasal antihistamines and nasal corticosteroids for treatment of nasal symptoms. A step-wise approach for the treatment of asthma is recommended including the use of inhaled corticosteroids, long-acting 2 agonists, leukotriene modifiers and immunologic agents. Allergy immunotherapy by either subcutaneous injection or sublingual tablets is the most effective long term treatment for dust mite allergies available. Effective treatment with allergen specific immunotherapy has been shown to decrease the progression of respiratory allergic diseases and even prevent the development of asthma in children. For more information regarding the diagnosis and treatment of dust mite allergies, please call your local Allergy Partners office for an appointment.

Dr. Elizabeth Majeski

Allergy Partners of Charleston

  • Providers
  • Services
  • Conditions
  • About Us
  • Careers
  • Find A Location
  • Patient Resources
  • Become an Allergy Partner
  • Blog
  • Allergy Partners Shop
Allergy Partners Home
  •  

© 2024 All Rights Reserved.

    • Notice of Privacy Practices
    • Patient Rights
    • Site Privacy Policy
    • Site Terms of Use
    • Site Accessibility
    • Site Search
    • Employee Healthcare Info
    • Site Map

Filed Under: Environmental Allergy

Comorbidities of Allergic Rhinitis

March 17, 2023 by

Comorbidities of Allergic Rhinitis

by Allergy Partners
March 17, 2023

Elderly woman covering nose

Allergic rhinitis is an increasingly common condition with typical symptoms of itchy and runny nose, sneezing, nasal congestion, and postnasal drainage. Frequently brushed off as “a pesky runny nose”, it has been shown that allergic rhinitis is often not an isolated disorder, but coincides with a multitude of other conditions including asthma, sinusitis, conjunctivitis, chronic otitis media, tonsillar and adenoid hypertrophy, sleep apnea, snoring, pharyngitis, laryngitis and disordered sleep. Allergic rhinitis and related comorbidities often negatively impact quality of life.

Allergic rhinitis results from an abnormal immune response to substances encountered in the environment such as pollens, pet dander, mold, and droppings from dust mites and cockroaches. The incidence of allergic rhinitis is estimated at 10-30% of the world’s population and symptoms are often under-recognized and undertreated. It has also been shown that poorly controlled allergic rhinitis is an exacerbating factor for asthma based on a shared common inflammatory pathway and the concept of “one airway”. Controlling allergic rhinitis is a key to maintaining asthma control. Recurrent sinus infections and worsening conjunctivitis are also often related to uncontrolled allergic rhinitis.

Identifying specific allergens with allergy testing allows customization of a treatment plan to include avoiding allergens, medications, and immunotherapy. Immunotherapy is the only therapy that treats the underlying cause, hence not only reducing pesky nasal symptoms, but significantly impacting eye symptoms, asthma and all the other associated disorders. Studies have shown that treating allergic rhinitis with immunotherapy not only improves allergic asthma, but can prevent it from occurring by eliminating the immune system response to potential triggers.
Don’t brush off a runny nose. Likely there are many other related symptoms that can be influenced by adequately treating allergic rhinitis.

Madeline Dillon, MD
Allergy Partners of Charlottesville

References:
Hadley JA, Derebery MJ, Marple BF. Comorbidities and allergic rhinitis: not just a runny nose. J Fam Pract. 2012 Feb;61(2 Suppl):S11-5.

Meltzer EO, Gross GN, Katial R, Storms WW. Allergic rhinitis substantially impacts patient quality of life: Findings from the Nasal Allergy Survey Assessing Limitations. J Fam Pract. 2012;61(suppl 1):S5-S10.
World Health Organization. White Book on Allergy 2011-2012 Executive Summary. By Prof. Ruby Pawankar, MD, PhD, Prof. Giorgio Walkter Canonica, MD, Prof. Stephen T. Holgate, BSc, MD, DSc, FMed Sci and Prof. Richard F. Lockey, MD.
Summary Health Statistics for U.S. Adults: National Health Interview Survey, 2010. By Jeannine S. Schiller, M.P.H., Jacqueline W. Lucas, M.P.H., Brian W. Ward, PhD and Jennifer A. Peregory, M.P.H., Division of Health Interview Statistics.
Bachert C, Vignola AM, Gevaert P, Leynaert B, Van Cauwenberge P, Bousquet J. Allergic rhinitis, rhinosinusitis, and asthma: one airway disease. Immunol Allergy Clin North Am. 2004;24(1):19-43.

  • Providers
  • Services
  • Conditions
  • About Us
  • Careers
  • Find A Location
  • Patient Resources
  • Become an Allergy Partner
  • Blog
  • Allergy Partners Shop
Allergy Partners Home
  •  

© 2024 All Rights Reserved.

    • Notice of Privacy Practices
    • Patient Rights
    • Site Privacy Policy
    • Site Terms of Use
    • Site Accessibility
    • Site Search
    • Employee Healthcare Info
    • Site Map

Filed Under: Environmental Allergy

Effects of Secondhand Smoke

March 1, 2023 by

Effects of Secondhand Smoke

by Allergy Partners
March 1, 2023

Smoking

There has been mounting evidence connecting exposure to secondhand smoke to illness and diseases due to the irritating nature of tobacco smoke on the non-smoker.

Despite significant educational efforts, epidemiologic evidence, and reports from the United States Surgeon General, smoking and smoking-related conditions are a major health concern. The irritating nature of tobacco smoke on the non-smoker has long been recognized. Since the 1960’s, there has been mounting evidence connecting exposure to secondhand smoke to illness and disease.
Secondhand smoke is a term used for the involuntary exposure of nonsmokers to tobacco smoke from smokers. Another commonly used term is Environmental Tobacco Smoke. Secondhand smoke is a mixture of side stream smoke given off by the smoldering cigarette, pipe, or cigar and mainstream smoke exhaled into the air by active smokers. Third hand smoke refers to smoke components deposited on surfaces.

In the News:

The Global Burden of Disease Study done in 2010 estimated that exposure to secondhand smoke is responsible for 601.000 premature deaths annually worldwide. It is estimated that 28% of the mortality and 61% of the morbidity is seen in children. Secondhand smoke has been found to be a cause of lung cancer by several epidemiologic studies. Cardiac disease has also been causally associated with secondhand smoke exposure in adults. Mounting evidence also points to secondhand smoke exposure as a cause or aggravator of a variety of adverse respiratory conditions including asthma, pneumonia, bronchitis, reduced lung function, sinusitis, and COPD. Secondhand smoke exposure is also implicated as a cause of middle ear disease, sensorineural hearing loss, sudden infant death syndrome, prematurity, impaired fetal growth and development, dental caries, cancers in locations other than the lungs, renal disease, and atherogenesis.

How It Can Affect Your Family:

The level of tobacco exposure of the fetus of a mother who smokes is the same as the level for an active smoker. There is a higher risk of stillbirth and neonatal deaths among newborns of smoking mothers. Maternal smoking during pregnancy reduces birth weight on an average of 200 grams. Active smoking of the mother during pregnancy is also associated with an increase in a large variety of non-chromosomal birth defects. Cognitive deficits tend to be more prevalent in children whose mothers smoked during pregnancy. Exposure of the non-smoking mother to secondhand smoke during pregnancy has been associated with an increased incidence of low birth weight, stillbirth, and congenital malformations.
The Global Study of Disease Burden from exposure to secondhand smoke estimates that 165,000 children under the age of 5 worldwide die annually because of lower respiratory infections attributed to secondhand smoke exposure. Chronic exposure to secondhand smoke is linked to an increased prevalence and severity of asthma. There is also evidence that secondhand smoke exposure promotes and facilitates allergic sensitization. Children with chronic secondhand smoke exposure enter adulthood with less pulmonary reserve and decreased lung function.
Exposure of children and adolescents to parental smoking has been associated with advancement of the vascular age by 3.3 years by measurement of carotid artery thickness. This increases the risk of developing carotid atherosclerotic plaques in adulthood even with adjustments being made for other risk factors such as blood pressure, lipid levels, and personal smoking status. There is growing concern about increased risks of coronary artery disease in adults and children exposed to secondhand smoke.

What Can I Do?

Reducing and preferably eliminating secondhand smoke in the home and in vehicles is critical since these are the major locations of exposure for children and non-smoking adults. Secondhand smoke cannot be controlled by air cleaning and filtration, or building ventilation. These findings on the effects of secondhand smoke are the foundation for the drive for smoke-free indoor environments and for educating parents and the community on the adverse health effects. Policies that ban all indoor smoking in workplaces and public places are highly effective in reducing smoke exposure. Only complete bans of smoking in indoor environments are effective. Segregation of smokers and non-smokers within the same indoor environment may reduce some of the exposure, but does not eliminate it.

Bonita Wilson, MD

  • Providers
  • Services
  • Conditions
  • About Us
  • Careers
  • Find A Location
  • Patient Resources
  • Become an Allergy Partner
  • Blog
  • Allergy Partners Shop
Allergy Partners Home
  •  

© 2024 All Rights Reserved.

    • Notice of Privacy Practices
    • Patient Rights
    • Site Privacy Policy
    • Site Terms of Use
    • Site Accessibility
    • Site Search
    • Employee Healthcare Info
    • Site Map

Filed Under: Environmental Allergy

Atopic Dermatitis (Eczema)

February 24, 2023 by

Atopic Dermatitis (Eczema)

by Allergy Partners
February 24, 2023

Eczema

Atopic dermatitis (eczema) is a chronic inflammatory skin disorder common in patients and families who have allergic diseases. It affects 10-20% of children and 1-3 % of adults. It usually occurs before the age of 5 years old in most patients although it can develop in adulthood in up to 20% of patients. Atopic dermatitis can also be the beginning of the “allergic march” in many patients who later develop asthma, allergic rhinitis, or both.

Atopic dermatitis is diagnosed clinically by the typical presentation of skin lesions. The rash is itchy and red with eczematous areas that are relapsing in nature. Children usually have the rash on their face, neck, wrists, hands, ankles, and feet. Older children and adults have lichenification (rough, scaly skin) and hyperpigmentation in the flexural folds (elbows, knees) of the extremities. For some patients, allergy testing may help identify potential triggers (environmental or food allergies) that, if avoided, could reduce the rash.

Numerous triggers can worsen atopic dermatitis. These include temperature, humidity, irritants, infections (bacterial and viral), food, inhalant and contact allergens and emotional stress. These should be addressed in each patient to maximize treatment of their atopic dermatitis.

Treatment of atopic dermatitis includes restoring a healthy skin barrier and controlling inflammation. Daily hydration (soaking in lukewarm water for 10-20 minutes daily) and judicial use of skin moisturizers (i.e. lotions, creams, balms, etc.) is the first step to improving the skin barrier. Applying moisturizers several times per day is vital. For severe disease, topical steroids can reduce skin inflammation, but care must be taken to limit their use in order to minimize side effects such as thinning of skin, loss of pigmentation, and stretch-mark formation. In addition, steroid-sparing disease modifying ointments are FDA approved for patients >2 years old and can be used daily to control the skin rash. These include tacrolimus (Protopic), pimecrolimus (Elidel), and crisaborole (Eucrisa).

In 2017, the first biologic medicine was approved by the FDA for atopic dermatitis. Dupilumab (Dupixent) is approved for patients 12 years and older for moderate to severe atopic dermatitis, is given every 2 weeks by subcutaneous injection at home, and has shown vast improvement in patients’ symptoms.

Other complementary treatments include antihistamines to help control itching, bleach baths to decrease bacterial skin colonization, supplementation of Vitamin D in deficient patients, and immunotherapy (allergy shots).

Medications that modify the immune system such as cyclosporine, mycophenolate mofetil, azathioprine, methotrexate, interferon gamma, and systemic corticosteroids have been used in severe cases resistant to other treatments but have significant side effects to consider. Phototherapy has been useful in some severe atopic dermatitis patients. Additionally, hospitalization may be needed for intensified treatments (i.e. wet to dry wraps) or addressing other aspects of the disease such as sleep disturbance, psychosocial issues, separation from environmental allergen exposure, and improving adherence to treatment regimen.

Atopic dermatitis is a chronic disease, but with a multi-tiered approach directed by an allergy specialist at Allergy Partners, patients can successfully manage this disease and dramatically reduce its negative impact on their lives.

By Dr. Tracie Overbeck
Allergy Partners of Central Kentucky

  • Providers
  • Services
  • Conditions
  • About Us
  • Careers
  • Find A Location
  • Patient Resources
  • Become an Allergy Partner
  • Blog
  • Allergy Partners Shop
Allergy Partners Home
  •  

© 2024 All Rights Reserved.

    • Notice of Privacy Practices
    • Patient Rights
    • Site Privacy Policy
    • Site Terms of Use
    • Site Accessibility
    • Site Search
    • Employee Healthcare Info
    • Site Map

Filed Under: Eczema

Asthma Therapy 101

February 18, 2023 by

Asthma Therapy 101

by Allergy Partners
February 18, 2023

woman jogging at the park

If you have asthma, it is important to know the role of the different medications used for asthma and how they should be used to best control asthma.

The characteristic symptoms of asthma are cough, wheeze, shortness of breath, chest tightness. These symptoms can lead to difficulty with exercise, activities and with sleep. The goals of asthma therapy are to reduce symptoms, reduce the need for rescue inhaler and reduce the risk of exacerbations (worsening asthma symptoms that may require oral steroids, like prednisone). Health care providers will assess asthma control over time and add and adjust medications, in a step-wise approach, until asthma is controlled. Control of asthma means a patient is having infrequent symptoms (<2x/week), minimal disruption in activity, no nighttime awakenings due to asthma and is not requiring rescue medication often.

Rescue medications, typically albuterol, are inhalers (medications delivered to the lungs) used when symptoms are present. When used effectively, these medications improve symptoms within minutes. They work by relaxing the muscles in the airway, which allows the airways to open. Your doctor may suggest a spacer or valved holding chamber device, which helps hold the medication so it can be effectively delivered to the lungs. Rescue inhalers should be carried by asthma patients all the time, to treat any symptoms quickly.

If an asthma patient’s symptoms are occurring often (≥ 2x/week) or if a patient is waking up at night with asthma symptoms, a controller medication is added to the regimen. Controller medications are medications patients taken every day to prevent symptoms. These medications should be taken daily or twice daily. Most of these controller medications are inhalers. The inhalers typically contain inhaled steroids, which decrease the inflammation (or swelling) in the airway. Some controller medications are combination medications, which are generally prescribed if symptoms require a higher level of treatment. These combination medications contain both an inhaled steroid as well as a long acting beta agonist (LABA) which is a long acting form of albuterol. If asthma is not well controlled with a combination medication, a separate inhaler may be added to help open the airways even more or an injected therapy may be considered (biologic medications designed to target specific pathways in asthma).

Achieving asthma control is important to help minimize disruption in activity, sleep and exercise. It is also important to understand triggers (environmental allergens, temperature, exercise, etc) for your asthma. Working with your trusted Allergy Partners physician can help you find any underlying triggers and understand how to avoid these triggers as well as manage your asthma.

  • Providers
  • Services
  • Conditions
  • About Us
  • Careers
  • Find A Location
  • Patient Resources
  • Become an Allergy Partner
  • Blog
  • Allergy Partners Shop
Allergy Partners Home
  •  

© 2024 All Rights Reserved.

    • Notice of Privacy Practices
    • Patient Rights
    • Site Privacy Policy
    • Site Terms of Use
    • Site Accessibility
    • Site Search
    • Employee Healthcare Info
    • Site Map

Filed Under: Asthma

Are Nasal Sprays Addictive?

February 13, 2023 by

Are Nasal Sprays Addictive?

by Allergy Partners
February 13, 2023

man crying

Allergy Partners’ Myth Busters Investigate

It’s natural to be concerned about taking any medication consistently, but this worry can be especially pronounced when dealing with nasal sprays. There have been some articles circulating lately claiming that these treatments are addictive, so it is understandable why you may feel hesitant or overwhelmed. Rest assured: you do not need to fear powerful decongestants and allergy medicines! In fact, treating your symptoms properly using prescription-strength medications can greatly reduce your suffering – without risking addiction.

Rebound Effect Vs. Addiction

What many patients are referring to when talking about getting addicted to nasal sprays is not addiction, but a rebound effect from using these types of decongestant medications. If used for more than five days straight, your body may become less responsive and require higher doses in order to reduce congestion. Luckily there’s an easy way around this: alternate every day between medications like antihistamines or even saline solutions so that you can avoid getting stuck with symptoms again.

Relief from allergies is possible with the daily use of nasal steroids or antihistamine sprays. Both prescription and over-the-counter formulations are available for safe, long-term symptom control. Your Allergy Partners allergist can help determine what treatment method works best for your specific allergy needs so that you can breathe easily again.

Alternatives to Nasal Sprays

Allergy nasal sprays are the most common treatment for allergies and they can be helpful in providing relief from congestion, nasal itching, sneezing, and other allergy symptoms. However, there are alternative options available to those who do not wish to use these prescription medications. Antihistamines taken orally are a great alternative for treating allergies and can provide quick relief of symptoms.

Nasal irrigation with a neti pot or saline spray is also an effective treatment for relieving congestion caused by allergies. Additionally, natural herbal remedies such as stinging nettle or butterbur have been used as traditional treatments for allergies and may offer some relief without many of the side effects associated with medication.

Allergy Myth: Busted!

Fear not, the myth of addictive nasal sprays has been DEBUNKED! But beware, overusing those decongestant sprays can have you trapped in a congestion cycle. Fear not, your trusty Allergy Partners physician is ready to recommend the ideal allergy treatments tailored just for you.

Find Answers at Allergy Partners

Whether you’re dealing with seasonal or chronic allergies, the team at your local Allergy Partners can help you better understand what is bothering you and help you find some relief. We take the time to learn about your experience so that we can personalize a treatment plan that perfectly targets your needs.

Find a location near you to schedule an appointment with our premier allergists today – they’re backed by Allergy Partners’ national network of board-certified physicians. Relief from symptoms is closer than you think.

  • Providers
  • Services
  • Conditions
  • About Us
  • Careers
  • Find A Location
  • Patient Resources
  • Become an Allergy Partner
  • Blog
  • Allergy Partners Shop
Allergy Partners Home
  •  

© 2024 All Rights Reserved.

    • Notice of Privacy Practices
    • Patient Rights
    • Site Privacy Policy
    • Site Terms of Use
    • Site Accessibility
    • Site Search
    • Employee Healthcare Info
    • Site Map

Filed Under: Resources

COVID Vaccine FAQ

February 12, 2023 by

COVID Vaccine FAQ

by Allergy Partners
February 12, 2023

Celebrating No COVID

The doctors at Allergy Partners have been following the pandemic, including vaccine development, testing and distribution closely on your behalf. The approval of the first COVID-19 vaccines by Pfizer and Moderna has been met with enormous public interest and generated a lot of questions and we’d like to answer some of them here:

Who should get the vaccine?
• Almost all adults should get vaccinated

Can children get the current vaccines?
• No vaccine has yet been approved for children under 16 and children should not be vaccinated until studies are complete and a vaccine has been approved for their age group.

Can people with immune deficiencies get the vaccine?
• Because there are more than 450 immunodeficiencies, it is not possible to make a blanket recommendation, but, because none of the vaccines are live, there is no additional risk to immunodeficiency patients.
Because it appears that most immunodeficiency patients infected with coronavirus have not had serious COVID-19 disease, primary immunodeficiency may not be considered a high-risk condition in your state.

Can people with asthma get the vaccine and are they considered at particular risk for serious COVID-19?
• Yes, people with asthma can receive the vaccine. At this time, the best evidence available is that people with asthma, except for some with very severe asthma, are not at increased risk for serious COVID-19 disease and, therefore, are not in a high-risk group.

Do the vaccines work?
• Yes. Extensive clinical trials show that the approved vaccines are clearly effective. Both have been shown to be 94-95% effective in preventing the spread of COVID-19.

Is one vaccine better than another?
• There are more vaccines coming but we don’t know their study results yet. At this time, there is no basis to prefer one vaccine over another.

Are the vaccines safe?
• Yes. Based on tens of thousands of vaccine recipients, the vaccines are safe As with any new medication, some very rare side effects may only be detected when large numbers of people have been vaccinated. There will be continued close monitoring of the safety of these new vaccines over time.

Are there side effects from the vaccine?
• As with all vaccines, rare side effects have occurred. The information about the vaccine reactions is limited but it is likely that some are allergic reactions and some are not.

Can the vaccines cause allergic reactions?
• Rare cases of allergic reactions to have been reported. There is a suspicion that an additive, polyethylene glycol, has triggered at least some of the allergic reactions. Allergy to polyethylene glycol is rare.

If I have had food, stinging insect, medication allergies or hay fever, can I get the vaccine?
• Yes. People with these types of allergy can receive the vaccine, but should be monitored after the vaccine for at least 15 minutes after the vaccine.

If I have had an allergic reaction to other vaccines, can I receive the COVID vaccine?
• Likely yes, but individuals who have previously experienced vaccine reactions should consult with their allergist about where to receive their vaccine and be monitored for at least 30 minutes after the vaccine

Where can I learn more about allergies and the vaccine?
• Go HERE

If I get the COVID vaccine, when can I get my allergy shots?
• While there is no data on this, our recommendation is to receive you not receive your allergy shot and COVID vaccine at least one day apart.

How will the vaccine be distributed?
• Distribution of the vaccine will vary by state. Be sure to check your state health department’s web site for information

When will everyone have access to the vaccine?
• It is unlikely that vaccine will be available for the general public until March or April

For more information, please see this post from Johns Hopkins University. As things are changing so rapidly, we will update you as new information becomes available.

By: Dr. Richard Wasserman

Allergy Partners of North Texas

  • Providers
  • Services
  • Conditions
  • About Us
  • Careers
  • Find A Location
  • Patient Resources
  • Become an Allergy Partner
  • Blog
  • Allergy Partners Shop
Allergy Partners Home
  •  

© 2024 All Rights Reserved.

    • Notice of Privacy Practices
    • Patient Rights
    • Site Privacy Policy
    • Site Terms of Use
    • Site Accessibility
    • Site Search
    • Employee Healthcare Info
    • Site Map

Filed Under: Resources

Allergy Fellows: It’s never too early to start your job search

February 9, 2023 by

Allergy Fellows: It’s never too early to start your job search

by Allergy Partners
February 9, 2023

woman typing on computer

Allergy practices commonly plan for new providers at least a year in advance. Making inquiries early gives both parties ample opportunity to make a good match.

Starting your post-fellowship career planning, even in the first year of your program, can ensure that your dedication is rewarded with a placement ideal for you and your family.

Most physicians, as they work through residency and fellowship, have a good idea about where they would like to build their careers. Whether it’s a hometown or favorite destination, the magic happens when that desire aligns with market factors and, ideally, a practice looking to add a physician to your timeline. Many practices have 3-5 year plans that identify key growth markets, as well as locations where a new physician should be added to keep up with demand or to replace physicians planning to retire.

In other words, your post-fellowship job might already be out there.

Start Looking for Allergy and Immunology Jobs

Ideally, you should begin reaching out in your first year or second year of fellowship, although there’s no harm in starting to form relationships with your target practices even earlier.

  • Start the conversation by attending Academy and College meetings and stopping by booths on the exhibitor floor. Practice representatives will be able to share early growth plans in the areas in which you’re interested and can even put you in touch with physician ambassadors already in practice there.
  • Attend virtual and in-person career fairs specific to allergists.
  • Keep an eye on the Academy and College job boards and set alerts for your favorite locations.
  • Search the internet and bookmark target practices.
  • Follow practices on LinkedIn and other social media platforms.
  • Reach out to physicians that you know and ask them about their experience with their practice. Would they recommend it?
  • Introduce yourself to physicians in your target area and ask if they’d let you shadow. Tell them your plans and ask for their advice. They might have plans to add a physician that matches your timeline.

Know the Timelines

The interview, negotiation, and contracting timeline varies by practice, but most would agree that a compact and meaningful process is best for all parties. You should expect a timely response from a practice with which you’re interviewing but understand that the complexities of a larger practice might add to the turnaround time.

If you are applying for a job that has already been identified by the practice, the entire process should take about 8-12 weeks from the first conversation to a fully executed contract. Salary and other negotiations will add to this timeline. If you are reaching out to a practice early in your fellowship, you should expect to be in conversation with them for a year or more. However, once an opportunity has been identified, a practice may be comfortable signing a contract a year in advance of your start date. You can then focus solely on your studies for the remainder of your program.

Licensing and credentialing add a few months to the post-contract process. It’s a good idea to apply for your state license while you’re still in early conversation with a practice because credentialing with payors cannot begin until a state license is received and can commence only after July 1 following completion of your fellowship. From that point, the process takes 90-120 days to be fully credentialed with payors. That puts most physicians coming out of fellowship on track to start seeing patients about October.

Keeping in Touch

Larger practices will have a system of tracking candidate interest, but don’t be afraid to check in periodically. If you’re early in a search and your plans change, let practices with whom you’ve been in contact know that you are looking at different options or locations. They will appreciate the communication.

At Allergy Partners, our director of recruiting maintains a database that cross-references candidate interest with our growing footprint. We love to speak with Fellows early in their program so that we can identify and align potential synergies between candidates and our growth initiatives. In many situations, we’re able to complete the interview process well in advance of graduation (as much as a year) so that you can focus your attention on your training, knowing you have a job waiting for you.

  • Providers
  • Services
  • Conditions
  • About Us
  • Careers
  • Find A Location
  • Patient Resources
  • Become an Allergy Partner
  • Blog
  • Allergy Partners Shop
Allergy Partners Home
  •  

© 2024 All Rights Reserved.

    • Notice of Privacy Practices
    • Patient Rights
    • Site Privacy Policy
    • Site Terms of Use
    • Site Accessibility
    • Site Search
    • Employee Healthcare Info
    • Site Map

Filed Under: Pathway to Partnership

Do Inhaled Corticosteroids (ICS) Stunt Growth?

January 20, 2023 by

Do Inhaled Corticosteroids (ICS) Stunt Growth?

by Allergy Partners
January 20, 2023

Young girl playing in field

Our Myth Busters Investigate

The question about corticosteroids (think inhalers) and their impacts on growth is an important one for our patients and parents. For many years, there has been concern over whether or not inhaled corticosteroids (ICS) – drugs taken to treat asthma and related respiratory disorders – may have potential side effects leading to delayed or stunted childhood growth.

Research has revealed that the use of ICS (inhalant corticosteroids) in children with asthma can have a slight but measurable negative impact on linear growth, weight gain, and skeletal maturation. It is recommended that minimal doses be used to avoid any potential adverse effects; however, further research shows asthmatic females and those tested positively for skin allergies are especially vulnerable to diminished growth when using these medications. The initial onset of decreased growth appears after one year without increased risks over time.

Recent studies have also revealed that intermittent use of ICS and intranasal steroids can be just as effective in treating asthma, yet with a significantly lower overall dose. This suggests an important opportunity for more targeted treatments to help children manage their asthmatic symptoms while minimizing negative growth effects.

Asthma Myth: Confirmed!

It’s encouraging to know that modern medical treatments such as inhaled and intranasal corticosteroid medications can help treat the symptoms of asthma in adults, even if their use may be associated with a slight decrease in overall height. The positive impact these medications have on managing asthma should never be underestimated. Not only do they provide relief from acute symptoms, but also reduce the likelihood of future attacks. For those who require regular treatment to manage the condition, there is undeniable peace of mind that comes with having access to these medications and their proven benefit of maintaining asthma control.

Contact Allergy Partners to Learn More

At Allergy Partners, our network of board-certified allergists are here for you, expertly diagnosing asthma and allergic conditions and formulating personalized treatment plans that work with your lifestyle while monitoring growth over time. Your health and wellness are our physicians’ top priority. If asthma is slowing you down, relief is in sight when you have our experienced professionals on your side.

Learn more about dealing with asthma and then find your nearest Allergy Partners office to schedule an appointment!

  • Providers
  • Services
  • Conditions
  • About Us
  • Careers
  • Find A Location
  • Patient Resources
  • Become an Allergy Partner
  • Blog
  • Allergy Partners Shop
Allergy Partners Home
  •  

© 2024 All Rights Reserved.

    • Notice of Privacy Practices
    • Patient Rights
    • Site Privacy Policy
    • Site Terms of Use
    • Site Accessibility
    • Site Search
    • Employee Healthcare Info
    • Site Map

Filed Under: Resources

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 116
  • Page 117
  • Page 118
  • Page 119
  • Go to Next Page »